These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 10391155

  • 1. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.
    Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, van Krieken JH, Hermans J, Leer JW, van de Velde CJ.
    Eur J Surg; 1999 May; 165(5):410-20. PubMed ID: 10391155
    [Abstract] [Full Text] [Related]

  • 2. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S, Sutton CD, Miller AS, Hemingway D, Leicester Colorectal Specialist Group.
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [Abstract] [Full Text] [Related]

  • 3. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D, Kyau-Ummen B, Halbfass HJ.
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group.
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
    Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA.
    J Clin Oncol; 2005 Sep 01; 23(25):6199-206. PubMed ID: 16135487
    [Abstract] [Full Text] [Related]

  • 8. Is pre-operative radiotherapy necessary in T-T rectal cancer with TME?
    Mackay G, Downey M, Molloy RG, O'Dwyer PJ.
    Colorectal Dis; 2006 Jan 01; 8(1):34-6. PubMed ID: 16519635
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Swedish Rectal Cancer Trial.
    Eur J Surg; 1996 May 01; 162(5):397-402. PubMed ID: 8781922
    [Abstract] [Full Text] [Related]

  • 14. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
    Vermaas M, Gosselink MP, Ferenschild FT, van den Aardweg E, Lont HE, Kemperman HW, van der Harst E, Tetteroo GW, Oostenbroek RJ, Dijkhuis CM, Eggermont AM, de Wilt JH.
    Eur J Surg Oncol; 2007 Sep 01; 33(7):862-7. PubMed ID: 17257804
    [Abstract] [Full Text] [Related]

  • 15. Surgical outcomes after total mesorectal excision for rectal cancer.
    Chiappa A, Biffi R, Bertani E, Zbar AP, Pace U, Crotti C, Biella F, Viale G, Orecchia R, Pruneri G, Poldi D, Andreoni B.
    J Surg Oncol; 2006 Sep 01; 94(3):182-93; discussion 181. PubMed ID: 16900534
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.
    Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Søreide O, Norwegian Rectal Cancer Group.
    Dis Colon Rectum; 2004 Jan 01; 47(1):48-58. PubMed ID: 14719151
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
    den Dulk M, Marijnen CA, Putter H, Rutten HJ, Beets GL, Wiggers T, Nagtegaal ID, van de Velde CJ.
    Ann Surg; 2007 Jul 01; 246(1):83-90. PubMed ID: 17592295
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.